The dominant lesion in ankylosing spondylitis (AS) is an inflammatory arthritis of the spinal and sacroiliac joints. However, it is complicated by peripheral arthritis in 50 % of cases, iritis in 30 %, and aortitis in 5% l.
there were significant correlations between CRP, C9, and fibrinogen (p=<0.01), suggesting that these APP may be more reliable indicators of disease activity. The mean values of the APP in those patients with a peripheral arthritis were significantly higher than in those with pelvospondylitis alone for ESR (p<0.01), CRP (p<001), and fibrinogen (p<005). The only significant difference between those patients with an iritis and those with only pelvospondylitis was an elevated CRP in the iritis group (p<0.01). This suggests that a peripheral arthritis is the most important cause of an elevated ESR or APP in ankylosing spondylitis. Serum immunoglobulins were also measured and they showed a significant elevation of IgA in all 3 patient groups, there being no difference between each group. Serum IgG was raised only in those patients with an iritis or peripheral arthritis, the IgM levels being within the normal range for all patient groups.
The dominant lesion in ankylosing spondylitis (AS) is an inflammatory arthritis of the spinal and sacroiliac joints. However, it is complicated by peripheral arthritis in 50 % of cases, iritis in 30 %, and aortitis in 5% l. Clinical assessment of spinal disease activity is difficult because there are few reliable signs, and there is a need for a reliable laboratory measurement of disease activity.
In rheumatoid arthritis the erythrocyte sedimentation rate (ESR) is the commonly used laboratory measure of disease activity, and its level usually correlates with clinical assessment of disease activity. 20 In this study there was no correlation between the APP levels and the clinical measurement of disease activity for the total patient group. A similar lack of correlation has been shown between clinical disease activity as measured by pain, and the ESR.2' This lack of correlation was also present in patients followed up longitudinally, only occasional patients showing a relationship between an APP and disease activity. The main reason for this lack of correlation is the difficulty in accurately assessing clinical disease activity in patients with only pelvospondylitis. Even though patients with a peripheral arthritis had higher mean levels of APP, there was not a significant correlation with disease activity.
The commonly used nonsteroidal antiinflammatory drugs (NSAID) do not influence the ESR or APP,22 so that their levels would more accurately reflect the degree of inflammation. In contrast to this, symptoms are significantly modified by NSAID medication, and this would give an erroneous clinical assessment of disease activity. In the pelvospondylitis subgroup there were correlations between the APP CRP, C9, and fibrinogen. This implies that the elevation of these 3 APPs could be more representative of the amount of inflammation than the clinical assessment.
The mean APP levels for the disease subgroups were interesting in that there was a marked difference between those with and without a peripheral arthritis. The ESR, CRP, fibrinogen, and C9 were significantly elevated in the peripheral arthritis group in comparison with those with only pelvospondylitis.
Cowling et al.23 found a correlation between ESR. CRP, and clinically assessed disease activity. This is in contrast to other reports that could not find an association between ESR and disease activity. One reason for this discrepancy might be that an important criterion in their classification of active disease was the presence of a peripheral arthritis. It is possible that the synovitis is responsible for the raised CRP and ESR rather than the pelvospondylitis.
Possibily because the synovitis produces a greater degree of inflammation than the pelvospondylitis it stimulates a greater APP response. It could also be a different type of inflammation, being the appropriate one to produce a significant APP response. In diseases in which several APP have been measured there is not always a simultaneous elevation of all APP. Examples of these observations are an elevation of haptoglobin, ceruloplasmin, and orosomucoid but not of a,-antitrypsin and CRP in systemic lupus erythematosus24 25 27 We also noted that in the pelvospondylitis group mean IgA levels were highest in those patients with a CRP greater than 15 mg/dl (150 mg/l). Mucosal-associated lymphoid tissue is an important source of serum IgA.
especially the polymeric fraction. The elevated serum IgA in ankylosing spondylitis suggests that the inciting antigen may be acting at a mucosal surface, the gastrointestinal tract being a possibility.
Mean serum IgG levels have also been shown to be highest in those patients with active dlisease ats measured by an elevated ESR and CRP. 8 27 In our study the highest mean levels were associated with a peripheral arthritis. Most reports have found serum IgM levels to be within normal limits.5`8
In conclusion, the acute-phase protein levels distinguish between the patients with pelvospondylitis alone and pelvospondylitis with a peripheral arthritis. However, the problem in defining active disease in patients with only pelvospondylitis still remains. In our study the fibrinogen, C9, and CRP correlated with each other and probably more accurately reflect inflammation than clinical assessment. They may be a more reliable method for measuring disease activity in patients with ankylosing spondylitis.
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